Navigation Links
Takeda to Acquire Inviragen, Inc.
Date:5/7/2013

) is transmitted via mosquito and can cause fever, headache, fatigue, nausea, vomiting, muscle pain, rash and joint pain in those infected. Approximately 30% of patients showing clinical signs experience incapacitating joint pain, or arthritis that may persist for weeks, months, or in some cases years. On rare occasions, CHIKV infection may lead to neurologic and hepatic disease with high illness and mortality rates. CHIKV is considered endemic in 34 countries in Europe, Australia, Asia and Africa.

About Inviragen, Inc.
Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's vaccine to protect against dengue fever is in Phase 2 clinical testing. A vaccine designed to protect children from hand, foot and mouth disease has completed Phase 1 clinical testing. Vaccines to protect against chikungunya and Japanese encephalitis, which affect millions of individuals in Asia, are in development.  Vaccines in preclinical research stages include vaccines to protect against new forms of influenza and a combination plague/smallpox vaccine for biodefense. Founded in 2005 with offices in Colorado, Wisconsin and Singapore, Inviragen's investors include EDBI (through Bio*One Capital, Singapore), Charter Life Sciences (Sunnyvale, CA), Venture Investors (Madison, WI), and Phillip Private Equity (Singapore). See www.inviragen.com for more details.

About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in '/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Responds to Verdict in Diabetes Drug Case
2. Takeda Launches New Subsidiary in Ecuador
3. Takeda lanza nueva subsidiaria en Ecuador
4. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
5. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
7. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
10. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
11. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... and DUBLIN , ... TNIB) ("we" or the "Company"), a biotechnology company ... for autoimmune diseases in emerging nations, today announced ... our common stock for DTC,s Deposit and Withdrawal ... Securities Transfer Service ("FAST") transfer agent as the ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has announced ... report to their offering. Diabetes is ... globe. Over 382 million people are estimated to be currently ... to 592 million by 2035. With a very high ... and India , an increasing ...
(Date:9/23/2014)... -- The Pennsylvania State Police will accept unwanted, expired and ... National Prescription Drug Take-Back Day. The service is free ... is a national initiative, conducted in partnership with the ... public to dispose of expired, unused or unwanted prescription ... From 10 a.m. to 2 p.m., unwanted prescription ...
Breaking Medicine Technology:TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Techne Corporation,s (NASDAQ: TECH ) financial results for ... First quarter earnings were $27.5 million or $.74 ... to $30.0 million or $.81 per diluted share after adjustment ... of inventory that was written-up to fair value as part ...
... PAREXEL International Corporation (NASDAQ: PRXL ... today announced that the Company has expanded ... dedicated support for their commercialization goals ... services to help clients maximize regional and global ...
Cached Medicine Technology:Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 2Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 3Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 4Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 5Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 6Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 7Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 8PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 2PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 3PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 4PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 5
(Date:9/23/2014)... September 23, 2014 Dr. Connie Casad has ... practices to new office space at 12200 Park Central Drive, ... the office will be Park Cities Aesthetics, Optimal Health and ... In announcing her move, Dr. Casad said, “The patients’ comfort ... they select, we want them to always feel like their ...
(Date:9/23/2014)... 23, 2014 (HealthDay News) -- Both drinking and getting ... for alcohol abuse by high school students, a new ... of high school students who drink, could help expand ... already drink, to stop them from becoming binge drinkers, ... age of first alcohol use and progression to first ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Grinnell ... community improvement projects in the Midwest. Working Together ... to three non-profit organizations with projects positively impacting ... our rural marketplace make their communities a better ... Advertising and Community Relations Barb Baker. “Their leadership—as ...
(Date:9/23/2014)... an exercise DVD that adds short breaks of physical ... found it had a high level of popularity with ... overly sedentary educational programs. , Called "Brain Breaks," the ... Program of the Linus Pauling Institute at Oregon State ... children in 5-7 minute segments of physical activity, demonstrated ...
(Date:9/23/2014)... Vancouver Electrician Contractors, Pro Ace, has ... electrical services in Vancouver, BC. The company will provide ... a small maintenance project or a large-scale new installation ... meet the needs of the individual commercial client. Pro ... of an affordable price. As a result, businesses of ...
Breaking Medicine News(10 mins):Health News:Dr. Connie Casad Moving to New Office Location 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2
... The spread of cancer cells in the tongue may be ... be controlled, according to new research at the University of ... poorly understood disease, says Xiaofeng "Charles" Zhou, assistant professor in ... lead researcher of the study. More than 90 percent ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, July ... of their favorite pastimes -- sitting around -- the shorter ... The effect remained even after researchers factored out obesity or ... according to a study of more than 120,000 American adults. ...
... London (July 23, 2010) Relationships hold the key ... need. However, researchers have pinpointed a mismatch between patients, ... what medical and family caregivers offer. New recommendations to ... Palliative Medicine , published by SAGE. The terms ...
... July 22 (HealthDay News) -- In a new study that ... researchers found that lung function didn,t improve in babies who ... help some infants. Laboratory tests have suggested that nitric ... premature newborns, who often can,t breathe properly because their lungs ...
... Ph.D., director of the Division of Allergy and ... MERIT Award to extend funding of his long-standing ... Rothenberg received the award from the National Institute ... his "stellar record of research accomplishment." ...
... changes in specific brain regions in female patients with irritable ... in the abdomen, along with diarrhea, constipation or both. ... McGill University, the study appears in the July issue of ... show that IBS is associated with both decreases and increases ...
Cached Medicine News:Health News:Gene may hold key to reducing spread of oral cancers 2Health News:The Longer You Sit, the Shorter Your Life Span: Study 2Health News:Relationships hold key to spiritual care 2Health News:Nitric Oxide Doesn't Seem to Help Preemies' Lungs: Report 2Health News:Doctor at Cincinnati Children's receives prestigious NIH MERIT Award 2Health News:Study finds structural brain alterations in patients with irritable bowel syndrome 2Health News:Study finds structural brain alterations in patients with irritable bowel syndrome 3
... The HDR disposable template is ... contamination and eliminate the need ... made with premium silicone molded ... ensures accurate needle placement while ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... Reusable Template is designed for use ... system for prostate brachytherapy. Please be ... software match the graphics on the ... pins protruding from lower surface which ...
... The latest introduction in the family of ... design of the stepping platform features a ... scale. The EXII steeping unit has a ... visual display of transducer position and a ...
Medicine Products: